At a recent medical conference, scientist and Harvard professor George Church presented an argument causing anxiety among healthcare investors: The days of CRISPR gene editing might be numbered. He called CRISPR a "blunt ax" and said "it's called editing, I think it's really genome vandalism." Church made the case that the biotechnology industry might be better off moving beyond cutting genomes and toward more precise gene-editing techniques.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,